Loading…
2 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 50,278 | 64,052 | 66,271 | 58,958 | 81,331 | 80,684 | 82,719 | 96,080 |
| EBITDA | 26,242 | 8,465 | 1,494 | 2,251 | 7,302 | 6,253 | 4,892 | 4,184 |
| Net profit | 877 | 2,644 | -4,296 | 503 | 4,731 | 3,008 | 250 | -1,293 |
| Total assets | 82,937 | 87,067 | 80,299 | 81,367 | 89,724 | 101,725 | 110,856 | 121,934 |
| n (companies reporting) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
GEL, thousands
| Company | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Vivo Medical Group | 36,924 | 50,165 | 53,792 | 48,198 | 63,833 | 61,705 | 62,856 | 73,245 |
| Bokhua Cardiovascular C… | 13,354 | 13,887 | 12,479 | 10,760 | 17,498 | 18,979 | 19,863 | 22,835 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.